About HDH Medical

HDH Medical Ltd. is bringing to market an innovative product line of BYFix vascular anastomotic devices, with their specialized delivery instruments, providing suture-less anastomosis of large blood vessels for laparascopic and open surgery. This is a significant improvement of the existing range of surgical treatment options for aortic aneurysms, arterial occlusions and traumas.
ByFix technology enables for the first time, a cheaper, less complicated and more flexible, minimally invasive (fully laparoscopic) alternative, which is applicable to a wider selection of patients, with significant medical and economic benefits over existing surgical techniques. 
HDH Medical holds ISO 13483:2003, ISO 9001:2000 and CAN/CSA ISO 13485:2000 certification and its products are CE Marked for open and laparoscopic procedures.
About HDH Medical
Here you can learn more about the HDH Products:  Open Surgery  |  Laparoscopic surgery

News & Events

September 2011

HDH Medical was announced as one of three winners of the "USI We Summit" competition

May 2011

First animal trial for minimal invasive thoracoabdominal aorta replacement  was  performed by Dr Terezia Andrasi in Bud

November 2010

The clinical trail for 16 patients operated for AAA is completed with favourable  results

May 2010

Successful Laparoscopic animal trial was performed by Dr. Jerome Cau in France.

April 2010

The company has expanded geography of its post-clinical trials

Past Events

Frost & Sullivan has selected HDH Medical Ltd. as the recipient of the 2007 European Frost & Sullivan Award

March 2010

The company has launched the sales for B.Y.Fix anastamotic device and tools in Europe.